4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-24-000198
Director sold 3,080 shares at an average $25.00 ($77,007)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SATO VICKI L Director | 2024-09-03 | Sale 10b5-1 | −2,980 | $24.99 | $74,470 | 116,276 | D: show line 1 in the form |
| SATO VICKI L Director | 2024-09-03 | Sale 10b5-1 | −100 | $25.37 | $2,537 | 116,176 | D: show line 2 in the form |
| Open-market sales · 3,080 sh · avg $25.00 · $77,007 | |||||||
Loading xslF345X05/wk-form4_1725483889.xml…